Challenges – Voltarene, Nurofen, Doliprane… Why the labs are still running after these drugs
Challenges magazine interviewed Alice Lhabouz, President and Founder of Trecento AM, about the non-prescription drug (“OTC”) market and its recent mergers and acquisitions. “The catalysts for the growth of this market are mainly of a demographic nature: the continuous aging of the world population, the prolongation of the life span, especially in developed countries, (…)”…